BAM15 vs 5-amino-1mq
BAM15 (C-tier) vs 5-amino-1mq (C-tier). mechanism, trials, claims vs data, dosing literature. side-by-side reference.
BAM15 — tier C
a preclinical mitochondrial protonophore that reduced fat gain and improved metabolic measures in mice, with no human exposure, dose-finding, or safety study.
BAM15 has a coherent mechanism and credible mouse metabolic data, but no human bridge and no basis for calling a research-chemical exposure safe.
0 human exposure studies · half-life 1.7 hours in mouse plasma after 10 mg/kg oral gavage; no human half-life · weight loss
5-amino-1mq — tier C
small-molecule NNMT inhibitor. reproducible mouse data, zero published human trials, recent community discussion driven primarily by vendor-affiliated commercial promotion.
small-molecule NNMT inhibitor. reproducible mouse data, zero published human trials, recent community discussion driven primarily by vendor-affiliated commercial promotion.
NNMT inhibitor · research · half-life not characterized in humans; mouse oral bioavailability adequate in published animal studies · weight loss
at a glance
- BAM15: tier C · 0 human exposure studies
- 5-amino-1mq: tier C · NNMT inhibitor · research
reptides grades the research record and cites the literature behind every call. research reference only; not medical advice.
